Hemagen Diagnostics Alpha and Beta Analysis

HMGNDelisted Stock  USD 0.0001  0.00  0.00%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Hemagen Diagnostics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Hemagen Diagnostics over a specified time horizon. Remember, high Hemagen Diagnostics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Hemagen Diagnostics' market risk premium analysis include:
Beta
0.0
Alpha
0.0
Risk
0.0
Sharpe Ratio
0.0
Expected Return
0.0
Please note that although Hemagen Diagnostics alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Hemagen Diagnostics did 0.00  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Hemagen Diagnostics stock's relative risk over its benchmark. Hemagen Diagnostics has a beta of 0.00  . The returns on DOW JONES INDUSTRIAL and Hemagen Diagnostics are completely uncorrelated. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Hemagen Diagnostics Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Hemagen Diagnostics market risk premium is the additional return an investor will receive from holding Hemagen Diagnostics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Hemagen Diagnostics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Hemagen Diagnostics' performance over market.
α0.00   β0.00

Hemagen Diagnostics Fundamentals Vs Peers

Comparing Hemagen Diagnostics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Hemagen Diagnostics' direct or indirect competition across all of the common fundamentals between Hemagen Diagnostics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Hemagen Diagnostics or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Hemagen Diagnostics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Hemagen Diagnostics by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Hemagen Diagnostics to competition
FundamentalsHemagen DiagnosticsPeer Average
Return On Asset-0.1-0.14
Profit Margin(0.22) %(1.27) %
Operating Margin(0.11) %(5.51) %
Current Valuation441.76 K16.62 B
Shares Outstanding15.5 M571.82 M
Price To Earning(0.17) X28.72 X
Price To Sales0.1 X11.42 X

Hemagen Diagnostics Opportunities

Hemagen Diagnostics Return and Market Media

The Stock did not receive any noticable media coverage during the period.
 Price Growth (%)  
       Timeline  

About Hemagen Diagnostics Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Hemagen or other pink sheets. Alpha measures the amount that position in Hemagen Diagnostics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Hemagen Diagnostics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Hemagen Diagnostics' short interest history, or implied volatility extrapolated from Hemagen Diagnostics options trading.

Build Portfolio with Hemagen Diagnostics

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Consideration for investing in Hemagen Pink Sheet

If you are still planning to invest in Hemagen Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hemagen Diagnostics' history and understand the potential risks before investing.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Commodity Directory
Find actively traded commodities issued by global exchanges
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.